A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer
出版年份 2015 全文链接
标题
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer
作者
关键词
-
出版物
BJU INTERNATIONAL
Volume 116, Issue 4, Pages 546-555
出版商
Wiley
发表日期
2014-11-19
DOI
10.1111/bju.12986
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer
- (2014) M. S. Gordon et al. CLINICAL CANCER RESEARCH
- Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection
- (2014) Pablo Penaloza-MacMaster et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- From Bevacizumab to Tasquinimod
- (2013) Michael T. Schweizer et al. CANCER JOURNAL
- The hurdle of antiandrogen drug resistance: drug design strategies
- (2013) Jill A Trendel Expert Opinion on Drug Discovery
- Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer
- (2013) M. Dror Michaelson et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour angiogenesis: an elusive target in castration-resistant prostate cancer
- (2013) Matthew D Galsky et al. LANCET ONCOLOGY
- Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
- (2013) Ian F Tannock et al. LANCET ONCOLOGY
- IL-17 mediates resistance to anti-VEGF therapy
- (2013) Eleni Maniati et al. NATURE MEDICINE
- An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
- (2013) Alicia S Chung et al. NATURE MEDICINE
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
- (2012) L. S. Rosen et al. CLINICAL CANCER RESEARCH
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- (2012) William Kevin Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies
- (2012) Olivier Nolan-Stevaux et al. PLoS One
- Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors
- (2011) D. Romero et al. CANCER RESEARCH
- Angiogenesis inhibitors in the treatment of prostate cancer
- (2010) Paul G Kluetz et al. EXPERT OPINION ON PHARMACOTHERAPY
- Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2010) Yang-Min Ning et al. JOURNAL OF CLINICAL ONCOLOGY
- Endoglin-Targeted Cancer Therapy
- (2010) Ben K. Seon et al. Current Drug Delivery
- Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises
- (2010) Jeanny B. Aragon-Ching et al. Journal of Oncology
- Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
- (2008) N. A. Dallas et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now